Effects of CAPAH, memantine, and rivastigmine on behavioral and cognitive functions of rats
Relevance. Alzheimer’s disease (AD) is a neurodegenerative disease characterized by cognitive and behavioral disorders. The drugs currently used in clinical practice can slow drug development but are usually associated with lifelong use because of the complexity of pathogenesis. Therefore, to correc...
Saved in:
| Main Authors: | D. O. Nikitin, I. I. Semina, A. V. Valeeva, A. V. Nikitina, A. Z. Khafizova, A. G. Ovchinnikova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC “Publisher OKI”
2024-11-01
|
| Series: | Фармакокинетика и Фармакодинамика |
| Subjects: | |
| Online Access: | https://www.pharmacokinetica.ru/jour/article/view/426 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of the possibility of correcting behavioral disorders in rats with a stereotaxic model of Alzheimer's disease
by: I. I. Semina, et al.
Published: (2023-05-01) -
Chronic intermittent hypoxia‐mediated cognitive dysfunction in ovariectomized rats
by: Emily C. Cheung, et al.
Published: (2025-08-01) -
A bespoke water T–maze apparatus and protocol: an optimized, reliable, and repeatable method for screening learning, memory, and executive functioning in laboratory mice
by: Jeremy Davidson Bailoo, et al.
Published: (2024-12-01) -
Rivastigmine interferes with the pharmacological activity of hydromethylthionine on presynaptic proteins in the line 66 model of frontotemporal dementia
by: Karima Schwab, et al.
Published: (2025-01-01) -
Clinicians’ Perspectives of Twice-Weekly Rivastigmine Patches for Alzheimer’s Disease Treatment in Spain: The VIITAL 2S Study
by: Piñol Ripoll G, et al.
Published: (2025-04-01)